# Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives

> **NCT00001529** · — · RECRUITING · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 500 (estimated)

## Conditions studied

- Graft-Versus-Host Disease
- Graft-versus-leukemia
- Donor Apheresis

## Interventions

- **DRUG:** G-CSF

## Key facts

- **NCT ID:** NCT00001529
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 1996-03-18
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001529

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001529, "Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00001529. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*